These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Luo XN; Reddy JC; Yeyati PL; Idris AH; Hosono S; Haber DA; Licht JD; Atweh GF Oncogene; 1995 Aug; 11(4):743-50. PubMed ID: 7651738 [TBL] [Abstract][Full Text] [Related]
11. Oxygen depletion during and after mTHPC-mediated photodynamic therapy in RIF1 and H-MESO1 tumors. Schouwink H; Oppelaar H; Ruevekamp M; van der Valk M; Hart G; Rijken P; Baas P; Stewart FA Radiat Res; 2003 Feb; 159(2):190-8. PubMed ID: 12537524 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis. Peretz D; Kimel N; Fujii DK; Neufeld G Cancer Res; 1993 Jan; 53(1):158-64. PubMed ID: 8416740 [TBL] [Abstract][Full Text] [Related]
13. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression. Radinsky R; Kraemer PM; Raines MA; Kung HJ; Culp LA Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5143-7. PubMed ID: 3474646 [TBL] [Abstract][Full Text] [Related]
14. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF). Shi YP; Ferrara N Biochem Biophys Res Commun; 1999 Jan; 254(2):480-3. PubMed ID: 9918864 [TBL] [Abstract][Full Text] [Related]
16. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes. Storer RD; Allen HL; Kraynak AR; Bradley MO Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293 [TBL] [Abstract][Full Text] [Related]
17. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. Reddel RR; Ke Y; Kaighn ME; Malan-Shibley L; Lechner JF; Rhim JS; Harris CC Oncogene Res; 1988; 3(4):401-8. PubMed ID: 3067190 [TBL] [Abstract][Full Text] [Related]
18. Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development. Missero C; Ramon y Cajal S; Dotto GP Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9613-7. PubMed ID: 1946376 [TBL] [Abstract][Full Text] [Related]
19. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice. Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541 [TBL] [Abstract][Full Text] [Related]
20. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells. Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]